The Vantage Urologic Institute is pleased to announce the launch of our free Men’s Health Screening Program. Free screenings will be offered daily Monday through Saturday.
Vantage Urologic Institute is proud to provide our patients with a safe and effective way to control discomfort and anxiety during urologic diagnostic and therapeutic procedures: PRO-NOX™ Nitrous Oxide Delivery System.
Rezūm is a treatment for BPH that can be performed in a clinic or out-patient setting. Rezūm uses the stored thermal energy in water vapor (steam) to treat the extra prostate tissue that is causing symptoms such as frequency, urgency, irregular flow,
The proven, minimally invasive treatment that fills the gap between prescription medications and more invasive surgical procedures.
Most men think of estrogen as exclusively a female hormone, but men also produce it. In fact, testosterone is the precursor of estradiol, an estrogen, and the primary female sex hormone. Testosterone is converted into estradiol via the aromatase enzyme.
A myriad of molecular-based risk assessment tests derived from serum, urine, and tissue have emerged to improve the specificity for detection and stratification of clinically significant prostate cancer.
Multiparametric magnetic resonance imaging (mpMRI) can be used in conjunction with the standard transrectal ultrasound (TRUS)-guided biopsy to improve detection of clinically significant prostate cancers.
Prostate multiparametric magnetic resonance imaging (mpMRI) has emerged as the imaging method best able to detect clinically significant prostate cancer and to guide biopsy.
Some men with early stage (localized) prostate cancer who previously had to choose between active surveillance and aggressive treatment with a greater risk for side effects, now have a new option for treatment, focal therapy.
Prostate cancer screening involves testing for prostate cancer in men who have no symptoms of the disease. This testing can find cancer at an early stage. However, medical experts agree that prostate cancer screening should not be routinely ordered for all men and that screening can lead to both benefits and harms.